“PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS” (2019) Scholar: National School of Leadership, 8(2.2). Available at: https://jconsortium.com/index.php/scholar/article/view/93 (Accessed: 9 March 2025).